Review Article
Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
Table 3
Sensitivity analysis of common pneumonia and COVID-19 pneumonia.
| Subject | Efficacy index | Effect value | 95% CI |
| Common pneumonia | Flu-like symptoms | WMD = −1.81 | −2.17, −1.47 | Sputum | WMD = −1.10 | −1.94, −0.52 | Pulmonary rales | WMD = −2.03 | −2.87, −1.21 | Pulmonary imaging improvement | WMD = −1.88 | −2.45, −1.37 | Curative effect | OR = 3.65 | 2.69, 5.13 | Healing period | WMD-1.68 | −2.80, −0.53 | Adverse reaction | OR = 0.75 | 0.50, 1.19 |
| COVID1-19 pneumonia | Flu-like symptoms | OR = 3.18 | 2.18, 4.63 | Sputum | OR = 4.30 | 0.36, 47.40 | Shortness of breath | OR = 10.62 | 2.80, 66.79 | Breathlessness | OR = 4.81 | 0.29.42.01 | Chest tightness | OR = 3.02 | 0.77, 28.11 | Pulmonary imaging improvement | OR = 1.77 | 0.95, 3.41 | Curative effect | OR = 2.49 | 1.58, 4.85 | Healing period | WMD = −2.06 | −4.01, 0.01 | Conversion of severe cases | OR = 0.46 | 0.10, 0.92 |
| All | Adverse reactions | OR = 0.74 | 0.54, 1.05 |
|
|
The sensitivity analysis results indicated that deleting individual studies would change the combined results of the meta-analysis. |